Hosted on MSN29d
NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term GuidanceThat partially reversed a shocking sell-off after Chief Executive Chris Smith announced his retirement ... which offers cancer diagnostics and pharma services, expects sales to grow 11% to 13% ...
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris Smith ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results